Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | MU380 |
| Synonyms | |
| Therapy Description |
MU380 is a selective inhibitor of CHK1, which increases sensitivity of tumor cells to DNA damaging agents, potentially resulting in decreased tumor growth (PMID: 28619751, PMID: 30975914, PMID: 32579780). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| MU380 | CHK1 Inhibitor 18 | MU380 is a selective inhibitor of CHK1, which increases sensitivity of tumor cells to DNA damaging agents, potentially resulting in decreased tumor growth (PMID: 28619751, PMID: 30975914, PMID: 32579780). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|